Literature DB >> 34882498

Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy Tolerability.

N Lynn Henry1, André Rogatko1, Patricia A Ganz1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34882498      PMCID： PMC8797605          DOI： 10.1200/JCO.21.02387

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  5 in total

1.  Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.

Authors:  Richard G Margolese; Reena S Cecchini; Thomas B Julian; Patricia A Ganz; Joseph P Costantino; Laura A Vallow; Kathy S Albain; Patrick W Whitworth; Mary E Cianfrocca; Adam M Brufsky; Howard M Gross; Gamini S Soori; Judith O Hopkins; Louis Fehrenbacher; Keren Sturtz; Timothy F Wozniak; Thomas E Seay; Eleftherios P Mamounas; Norman Wolmark
Journal:  Lancet       Date:  2015-12-11       Impact factor: 79.321

2.  Pathway to Precision Patient-Reported Outcomes.

Authors:  Tara L Kaufmann; Gabrielle B Rocque
Journal:  J Clin Oncol       Date:  2021-10-01       Impact factor: 44.544

3.  Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35.

Authors:  N Lynn Henry; Sungjin Kim; Ron D Hays; Marcio A Diniz; Michael Luu; Reena S Cecchini; Greg Yothers; André Rogatko; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2021-09-23       Impact factor: 50.717

4.  Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials.

Authors:  André Rogatko; James S Babb; Hao Wang; Michael J Slifker; Gary R Hudes
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

5.  On the properties of the toxicity index and its statistical efficiency.

Authors:  Zahra S Razaee; Arash A Amini; Márcio A Diniz; Mourad Tighiouart; Greg Yothers; André Rogatko
Journal:  Stat Med       Date:  2020-12-20       Impact factor: 2.373
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.